Iran Reveals COVID-19 Data For June 5
(MENAFN- Trend News Agency)
BAKU, Azerbaijan, June 5. As many as 53 people
have been infected with the coronavirus (COVID-19) in the past 24
hours in Iran, reads the statement of the Ministry of health and
Medical Education of Iran, Trend reports.
In addition, 3 people have died from the coronavirus over the
past day.
At the same time, the condition of 458 people remains
critical.
So far, more than 52.3 million tests have been conducted in Iran
for the diagnosis of coronavirus.
In total, about 150 million doses of vaccines have been used in
Iran so far. A total of 64.5 million doses have been used in the
first stage, 57.8 million doses - in the second stage, and 27.5
million doses – in the third stage.
Iran continues to monitor the coronavirus situation in the
country. According to recent reports from Iranian officials, over
7.23 million people have been infected, and 141,331 people have
already died.
Meanwhile, over 7.05 million people have reportedly recovered
from the disease. The country continues to apply strict measures to
contain the further spread of the virus.
Reportedly, the disease was brought to Iran by a businessman
from Iran's Qom city, who went on a business trip to China, despite
official warnings. The man died later from the disease. The Islamic
Republic announced its first infections and deaths from the
coronavirus on Feb. 19.
The outbreak in the Chinese city of Wuhan - which is an
international transport hub - began at a fish market in late
December 2019.
The World Health Organization (WHO) on March 11 declared
COVID-19 a pandemic. Some sources claim the coronavirus outbreak
started as early as November 2019.
---
Follow the author on Twitter:@BaghishovElnur
MENAFN05062022000187011040ID1104325839
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.